TABLE II.
n | Control |
ACh |
Antagonists |
ACh |
|||||
---|---|---|---|---|---|---|---|---|---|
MAP | HR | MAP | HR | MAP | HR | MAP | HR | ||
Atropine | |||||||||
Pons | 4 | 100 | 100 | 78.0 ± 5.9 | 117.5 + 8.8 | 101.3 ±2.2 | 96.8 ± 1.7 | 90.8 ±2.2** | 106.3 ± 4.3 |
Medulla | |||||||||
local (14 mM) | 8 | 100 | 100 | 68.4 ± 13.1 | 111.8 ± 12.8 | 101.4 ±2.7 | 99.1 ±2.0 | 85.5 + 10.2* | 104.1 ±5.2 |
IV (1 mg/kg) | 3 | 100 | 100 | 74.3 + 6.5 | 114.0 ±5.3 | 101.3 ±3.1 | 98.7 ±1.5 | 92.0 ± 4.4* | 102.3 ± 6.4 |
HMT (12.4 mM) | |||||||||
Pons | 4 | 100 | 100 | 83.0 ±5.4 | 112.0 ± 10.2 | 101.0 ±2’.2 | 98.0 ±0.8 | 83.8 + 6.9 | 110.8 ±9.4 |
Medulla | 3 | 100 | 100 | 61.3 ±3.2 | 111.0 ±12.1 | 100.0 ±4.6 | 101.0 ±3.6 | 64.0 ±3.0 | 109.3 ±10.1 |
P < 0.05,
P < 0.01, comparing cardiovascular changes induced by ACh injection alone with that produced by ACh injection after antagonists.